Context: Testosterone is the male sex hormone responsible for growth of secondary sexual character and accessory sex organs. Despite the effectiveness as a male sex hormone, testosterone causes Benign Prostatic Hyperplasia (BPH) resulting in urinary dysfunction. On the other hand, flutamide is a pure antitestosterone, which blocks the effects of Dihydro testosterone (DHT) at the testosterone receptor and prevents BPH. Therefore the present study was designed to observe the protective role of flutamide on testosterone induced prostatic hyperplasia.
urinary bladder and the proximal portion of the urethra. The prostate consists of branched tubuloacinar glands embedded in a fibromuscular stroma 1 . Clinically, prostate is an important pelvic organ for its affinity to diseases like benign prostatic hyperplasia. Testosterone is responsible for development of accessory sex organs and secondary sexual characteristics 2 . In the target tissue, testosterone is not the active form of the hormone, it is reduced to dihydrotestosterone (DHT) by an enzyme 5, α-reductase and is 10 times more potent than testosterone because it dissociates from the cellular testosterone receptor more slowly 3, 4 .
Growth of the prostate, normal and abnormal is mediated by testosterone. Benign Prostatic Hyperplasia (BPH) is a non-malignant enlargement of prostate gland that commonly develops in the aging male. It is a hyperplastic process of the stroma and epithelial tissues of the prostate gland. DHT binds to cytoplasmic receptor protein, forming complex then migrates to the nucleus and binds to the nuclear testosterone receptor and induces the DNA-RNA transcription process which is mitogenic and leads to hyperplasia of the target organ 4 .
Flutamide is a pure antitestosterone without significant progestogenic actions which blocks the effects of DHT at the testosterone receptor and prevents (BPH) 5, 6 . Mechanism of action of flutamide is the competition with testosterone for the testosterone receptor 7 . Flutamide is an effective drug in the treatment of BPH, which reduces hyperplasia of the prostate rapidly 8 .
Materials & method:
Forty five adult male rats of Long Evans strain weighing between 200-300 gms of age 8-10 weeks were used in the present study. All the rats were divided into three groups and were sacrificed on the eleventh day of study by decerebration under ether anesthesia.
Group A: Served as the vehicle control group and comprised of 15 rats, each rat received an injection of 0.2 ml of olive oil (vehicle) daily for 10 days.
Group B: Served as the testosterone control group and comprised of 15 rats, each rat received 0.32 mg testosterone propionate in 0.01 ml of suspension daily subcutaneously for 10 days.
Group C: Served as the flutamide treated rats and comprised of 15 rats, each rat received 0.32 mg testosterone propionate in 0.01 ml of suspension and flutamide 2.00 mg in 0.08 ml of suspension daily subcutaneously for 10 days.
Procedure for preparing histological sections:
Out of fifteen (15) prostates in each group, histological studies were carried out on 6 randomly selected specimens.
The ventral prostate was fixed in 10% formal saline solution and processed following routine histological procedure. The tissues were dehydrated in ascending concentration of alcohol, cleared in xylene, infiltrated and embedded in paraffin. Sections of the tissues of 6 mm (micrometer) thickness were made by a rotary microtome and were stained with haematoxylin and eosin (H&E).
Estimation of the stroma in the ventral prostate was done at low power field (X10 objectives x 10 eyepiece) of microscope:
The proportion of structural stroma of prostate were determined by using a 'Point Counting technique'. A replica of Zeiss integrating eyepiece was prepared The total number of points hitting inter-acinus prostatic stroma was summed up and expressed as a percentage of the total number of points. Table-II & Figure-3, 4 , 5, 6 shows the percentage volume of stroma between different groups of rats. The mean percentage volume of stroma in the vehicle control (Group A) rats was 14.83 ± 1.78. The mean percentage volume in the testosterone treated (Group B) was 20.25 ± 0.69 was higher than the vehicle treated rats. The mean percentage volume of stroma in flutamide treated group (Group C) was 15.00 ± 0.71. The value of this group was lower than that of testosterone treated rats. The mean difference was highly significant (P<.001) when compared between the groups. 
Results:

